Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Mahmoud Said

Mahmoud Said

Zagazig University, Egypt

Title: Ameliorative effect of Phoenix dactylifera on adverse effects of Linezolid in rats

Biography

Biography: Mahmoud Said

Abstract

Linezolid is one of the oxazolidinone anti-biotics that’s used to treat methicillin resistant staphylococcus aureus (MRSA) & vancomycin resistant staphylococcus aureus VRSA and was discovered in the 1990s and first approved for use in 2000. This study was aimed to investigate the adverse effects of linezolid on bone marrow, brain & kidney damaging effect of linezolid and counteracting these adverse effects using Phoenix dactylifera methanolic extract in rats. It was found that oral administration of linezolid (100 mg/kg body weight) given for 14 successive days induced a significant decrease in hemoglobin content (7.88±0.18 g/L) on the first day post-treatment, significant increase in serum urea (59.75±0.85) & serum creatinine (1.89±0.04) on the 14th day post- treatment and induced mild brain damage on the first day post treatment. The concurrent oral administration of Phoenix dactylifera methanolic extract (1000 mg/kg body weight) and linezolid (100 mg/kg body weight) for the same period corrected the damaging effects of linezolid of the hemoglobin content, urea, creatinine & brain condition of treated rats. It was concluded that methanolic extract of phoenix dactylifera clearly ameliorated these damaging effects of linezolid.